Dow Down 0.22% Nasdaq Up 0.14%

Cytokinetics, Incorporated (CYTK)

-NasdaqCM
4.30 Down 0.08(1.83%) Aug 22, 4:00PM EDT
Prev Close:4.38
Open:4.37
Bid:4.21 x 400
Ask:4.38 x 1600
1y Target Est:10.80
Beta:0.98
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:4.25 - 4.39
52wk Range:3.96 - 13.26
Volume:200,510
Avg Vol (3m):572,722
Market Cap:157.41M
P/E (ttm):N/A
EPS (ttm):-1.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTK

Comparison

Symbol% ChgMkt Cap
CYTKDown 1.83%157.41M
BIIBUp 0.39%80.28B
LGNDDown 0.99%1.06B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.99
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback